Early Funding for Category Defining Startups

Company Updates

Curebase Curebase attracts Gilead as backer in $40M financing to expand business.
Qulture.Rocks Qulture.Rocks acquired by edtech arm of Brazilian Grupo UOL.
Varos Varos emerges from stealth with $4M to revolutionize competitive analytics.
Living Carbon Living Carbon accounces that its trees increase CO2 absorption by more than 50%.
Memora Health Memora Health brings in $40M to grow its platform, expand partnerships.
Trestle Biotherapeutics Trestle Biotherapeutics emerges to bioprint implantable kidney tissues.
Zingbus Zingbus raises $6m from Indian and Silicon Valley investors.
UBITS UBITS closes $5m Series A investment round led by Owl Ventures.
Orbillion Bio Orbillion Bio's plans for lab grown Wagyu, beef, and elk eaten up by investors.
Mark Cuban's Cost Plus Drug Company Mark Cuban Cost Plus Drugs comes out of stealth.
Liftoff Liftoff receives close to $400 million from Blackstone for mobile app marketing.
Momentus Space Momentus to become latest space stock with ticker 'MNTS', valued at $1.2 billion.
Flat.mx Flat.mx raises $25M in financing to modernize buying homes in Mexico.
Carbon Chain Carbon Chain announces weekly Climate Memo newsletter.
Sequence Bio Sequence Bio launches pilot phase of N.L Genome Project to find disease-linked genes.
CB Therapeutics CB Therapeutics raises $7.5m to scale up biosynthesis research and production.
Cursor Cursor acquired by machine learning platform unicorn DataRobot.
Shone Shone launches autonomous cargo ships with shipping giant CMA CGM.
Frey Frey raises millions in venture funding in clothing care gold rush.
Pegasus Solar Pegasus Solar secures $10m Series A led by Ecosystem Integrity fund.

Team

Ben McCann

Ben was the Co-founder and CTO of Connectifier. Ben holds an MBA and B.S Computer Science from Carnegie Mellon.

Erik Buchanan

Erik was the VP of Eng at Connectifier and Head of Talent Relevance at LinkedIn. He's now a founder at CloseFactor.

Jobs

Our portfolio companies are hiring!

Investment

© 2019 C3 Ventures. All Rights Reserved.